NEW YORK (GenomeWeb News) – Natera recently announced two deals for the distribution of its Panorama non-invasive prenatal test outside the US.
Under one deal, the Joaquim Chaves Group will distribute the Panorama test in Portugal, and under the second deal, the Bangkok Cytogenetics Center will distribute the test in Thailand.
Financial and other terms of the agreements were not disclosed.
Using a blood draw, Panorama detects trisomy 21, 18, and 13, as well as monosomy X, triploidy, and sex chromosome aneuploidies. It uses Natera's algorithm called Next Generation Aneuploidy Testing Using SNPs to analyze cell-free DNA from both the mother and the fetus.
The two deals follow similar agreements recently inked by San Carlos, Calif.-based Natera to expand access to the test. In December, it and DiagCor announced an agreement covering Hong Kong. A month earlier, Natera reached a deal with Hospital Israelita Albert Einstein in São Paulo to offer the test.
Last month, Natera and pathology services provider ProPath inked a US distribution agreement.